Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,148,960
+$17,448 QoQ
Shares Held
4,524
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#2,871
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $5,862,596 across 10 Drug Manufacturers - General names. JNJ ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,191 | $1,428,521 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
4,524 | $1,148,960 | |
| 3 | AMGN |
Amgen Inc
|
2,998 | $1,085,635 | |
| 4 | ABBV |
AbbVie Inc.
|
4,023 | $1,012,347 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,345 | $558,332 | |
| 6 | PFE |
Pfizer Inc
|
11,663 | $280,845 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,319 | $166,642 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,274 | $131,027 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,148,960 | 4,524 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,131,512 | 4,629 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $940,380 | 4,544 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $825,860 | 4,454 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $633,607 | 4,148 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $726,545 | 4,381 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $455,842 | 3,152 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $573,692 | 3,540 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $517,114 | 3,538 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $530,411 | 3,353 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $541,379 | 3,454 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $505,408 | 3,245 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $575,347 | 3,476 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $376,650 | 2,430 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $491 | 3,579 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $588,096 | 3,600 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $583,652 | 3,288 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $606,481 | 3,422 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $579,071 | 3,385 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $499,681 | 3,094 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $443,644 | 2,693 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $270,684 | 1,647 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $259,204 | 1,647 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $245,205 | 1,647 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $231,476 | 1,646 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $215,708 | 1,645 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||